vaccine market

Top Reports

20 Dec 2022  |  Global

Advances and Growth Opportunities in RNA Vaccines

Technology Innovations and Investments Bolster Next-generation Prophylactic and Therapeutic RNA Vaccines

RNA therapeutics and vaccines have been around for a long time, but the COVID-19 pandemic enabled their mass-market commercialization. Industry players saw mRNA vaccines developed for COVID-19 as effective for reducing the impact of the SARS-CoV-2 virus in populations. Moderna emerged as the first player to develop and commercialize an mRNA vaccine...

18 Apr 2022  |  North America

Global Vaccine Growth Opportunities

Capability Expansion in Nucleic Acid-based Vaccines is Accelerating the Disruption in Vaccines Globally

Frost & Sullivan provides an outlook for the global vaccine industry for 2022 and beyond, including emerging trends and growth opportunities. Innovation, which remains mainstream in vaccine development, is augmenting investments by emerging vaccine developers in designing novel technology platforms, especially for nucleic acid-based vaccines. Spurr...

26 Nov 2021  |  Europe

EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities

Future Growth Potential Driven by Capabilities and Expertise in Vaccine Manufacturing

With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly,...

25 Aug 2021  |  Global

Emerging Materials Influence Global Vaccine Packaging: Technology Opportunity Analysis

Need for Better Primary Packaging Materials, Sustainable Options, and Customized Storage during Transport Drives New Product Development

The materials used for pharmaceutical vaccine packaging vary, and many are well-established in the market for the transport and storage of vaccines. Despite the wide variety, some of the most used vaccine packaging materials remain challenged by glass delamination, instability, and pH alteration over time. The global COVID-19 pandemic has amplified...

30 Apr 2021  |  North America

US COVID-19 Vaccines and Therapeutics Tracker—Market Insights and Trends, H1 2021

Agnostic Vaccine Platform Technology Enhancing Future Growth Potential of Participants in the Value Chain

This study by Frost & Sullivans Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants. T...

29 Oct 2020  |  Global

Frost Radar™:Transformative Influenza Vaccines, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Influenza causes respiratory diseases and often leads to large epidemics. Every year about 290,000 to 650,000 people die due to influenza worldwide. Anti-viral drugs available to treat influenza have many limitations making vaccination the most effective tool to prevent seasonal and pandemic influenza outbreaks. Influenza vaccination is highly reco...

02 May 2019  |  Global

Technologies Enabling Next Generation Vaccine Development

Upcoming Vaccine Technologies for Infectious Diseases

Vaccine Delivery platforms: This section covers various nanoparticle-based vaccine delivery platforms such as nanoparticles of biological (self-assembling proteins) and non-biological origin ( inorganic and polymeric). The biological nanoparticles subsection overlaps with virus-like particles that has been separately addressed. Virus-Like Parti...

25 Apr 2019  |  North America

Growth Opportunities in Global Vaccines Market, Forecast to 2024

Increased Investment in Adult Immunization and Improved Mammalian Cell-culture Expression Systems will Drive Growth and Profitability

The report provides an overview of the global vaccine market estimating the market size broken down by different segments. Vaccines, though a sub-set of biologics, have a completely different dynamic. Not only are they largely designed for a healthy cohort but are also exponentially influenced by government actions and policies. While old generatio...

13 Mar 2015  |  Asia Pacific

Analysis of the Global Vaccines Delivery Market

Innovative Technologies and Future Trends for Stakeholders

The global market for vaccines is estimated to be only 2-3% of the total pharmaceuticals market in 2014; however, this sector has been continuously experiencing a stellar growth rate of 10-15% per year versus the 5-7% seen in the overall market. Currently, the most commonly available vaccines are administered by injection, which makes mass immuniza...


This market insight presents an overview of the India contract research organization (CRO) market. It provides a revenue forecast for the market by phase and therapeutic type. The insight also discusses the major challenges, the unmet needs, and the emerging market trends. It analyzes the complete life cycle of the CRO market, from pre-clinical tr...


This issue of Vital Signs, released in August 2015, discusses The Real Fight Against Cancer: The Struggle to make Drugs Affordable, OPKO Health's acquisition of Bio-Reference Laboratories, Health Insurance Company Mergers  How will Consumers Fare?, and Illumina's acquisition of GenoLogics.


This research service examines and highlights the prevailing and the emerging trends of the Indian vaccine market to comprehend the market dynamics and identify the hidden potential growth segments. The primary objective of the study is to provide details about the overall market, including trends, and drivers and restraints. In addition, market se...

17 Dec 2012  |  Europe

Therapeutic Vaccines - A Leading Milestone


This article gives a detailed overview of the key technology trends in the therapeutic vaccines market. The current trends and product developments across the key therapeutic areas have been discussed.

09 Aug 2012  |  Europe

Analysis of the European Vaccines Market

Novel Technology Innovations and Therapeutic Vaccines are Likely to Revolutionise the Industry

The Research Service provides analysis and assessment of the European Vaccines Market, maps the key trends and dynamics shaping the industry sector, provides valuable insights on pipeline analysis and competitive landscape and discusses the strategic recommendations for the success of the market participants. This study provides an in-depth analysi...

20 Oct 2011  |  Global

Industry Insights on Vaccines (Technical Insights)

Strategic Portfolio Management, Trends and Prospects for Vaccines

Vaccine technologies have garnered increased interest from pharmaceutical companies and biotech companies in the last few years. Not only are there companies working on newer vaccine types, but also on platform technologies for delivery, production, adjuvants and so on. This study is aimed at delivering an overview of the research portfolio for vac...


This research service presents an analysis of the emerging vaccines market in India. It quantifies the market size, provides growth forecasts of the emerging vaccines market from 2008 to 2017. This research service provides in-depth analysis of industry challenges, market drivers and market restraints, and how they impact the market dynamics during...


This research service profiles technology market penetration and provides a roadmapping of the needle-free vaccine delivery technology segment. Incorporated analyses includes technology capability and value chain assessment, innovation and market potential assessment, technology assessment to name a few. Analysis of the business and technology acce...


This issue of Vital Signs, released on March 31, 2011, provides a strategic insight on the vaccines market. Additionally, a company spotlight is provided for Health Decisions, a CRO that has built a flexible global trial network that offers a structured, technology-backed clinical trial management model that focuses on improving speed and produ...

31 Dec 2009  |  Asia Pacific

Indian Vaccine Market


The research service presents a detailed market overview of all the major diseases like HiB, MMR, pneumococcal, rabies, typhoid, Hepatitis B and Hepatitis A. The research focusses on Market drivers, Market restraints and various industry challenges along with the revenue forecasts for the period of 2006-2016. The geographical scope of the research...

07 Dec 2009  |  North America

Global Vaccines Market


This research service covers the global vaccines market from 2005-2015. Included is discussion of issues such as key trends, products, challenges, drivers, and competitive structure. Revenue forecasts are also presented for the global market, North America, Europe, and Rest-of-World, with geographic and company market shares at the global level. Va...